Table 2.
Baseline demographic and clinical characteristics of the patients
| Group 1 (n = 23) | Group 2 (n = 59) | p value | |
|---|---|---|---|
| Male | 15 (65) | 30 (50) | 0.24 |
| Age, years | 67 ± 17 | 69 ± 14 | 0.68 |
| Time from symptom onset to ED, min | 145 ± 143 | 186 ± 224 | 0.42 |
| TIA symptom duration, min | 34 ± 40 | 42 ± 43 | 0.47 |
| Length of hospitalization, days | 2.13 ± 1.39 | 2.03 ± 0.82 | 0.82 |
| Diabetes mellitus | 4 (17) | 17 (28) | 0.32 |
| Hypertension | 17 (74) | 44 (75) | 0.50 |
| Hyperlipidemia | 12 (52) | 39 (66) | 0.24 |
| Atrial fibrillation | 6 (26) | 7 (12) | 0.06 |
| Left ventricular ejection fraction <30% | 2 (9) | 3 (5) | 0.54 |
| Antiplatelet use prior to the event | 11 (48) | 27 (46) | 0.86 |
| Anticoagulant use prior to the event | 7 (30) | 10 (17) | 0.17 |
| Systolic blood pressure at ED, mm Hg | 146 ± 20 | 149 ± 25 | 0.60 |
| Diastolic blood pressure at ED, mm Hg | 79 ± 11 | 75 ± 14 | 0.24 |
Values represent n (%) or mean ± SD.